We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
4626
DELISTED
Express, Inc.
EXPR
$0 ﹤0.01%
5
-98
-95% -$4.81K
NEPT
4627
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-7
Closed -$45.5K
BFX
4628
DELISTED
BowFlex Inc.
BFX
-310
Closed -$1K
MARK
4629
DELISTED
Remark Holdings, Inc.
MARK
-494
Closed -$4K
MDVL
4630
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
0
KERNW
4631
DELISTED
Akerna Corp Warrant
KERNW
$0 ﹤0.01%
8
DMK
4632
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-13
Closed -$1K
ORTX
4633
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-149
Closed -$21K
PATI
4634
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$0 ﹤0.01%
5
-295
-98% -$5.16K
PCTI
4635
DELISTED
PCTEL, Inc. Common Stock
PCTI
-983
Closed -$4K
SGEN
4636
DELISTED
Seagen Inc. Common Stock
SGEN
-122
Closed -$8K
CLRG
4637
DELISTED
IndexIQ ETF Trust IQ U.S. Large Cap ETF
CLRG
-221
Closed -$5K
HT
4638
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-54
Closed -$1K
ITCL
4639
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
-67
Closed -$1K
ARGO
4640
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-4
Closed
NXGN
4641
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$0 ﹤0.01%
+19
New +$316
ACER
4642
DELISTED
Acer Therapeutics Inc
ACER
-2,202
Closed -$8K
JPT
4643
DELISTED
Nuveen Preferred and Income Fund
JPT
-6
Closed
EMAN
4644
DELISTED
eMagin Corporation
EMAN
$0 ﹤0.01%
80
CEN
4645
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
-30
Closed -$2K
PRTK
4646
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-2,174
Closed -$9K
RTL
4647
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
-85
Closed -$1K
NEX
4648
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-20,901
Closed -$140K
AMRS
4649
DELISTED
Amyris Inc.
AMRS
$0 ﹤0.01%
+27
New +$101
KDNY
4650
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-888
Closed -$7K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.